<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               6	ADVERSE REACTIONS<BR>               <BR>                  The following adverse reactions are discussed in greater detail in another section of the label:<BR>                  <BR>                      Cutaneous Squamous Cell Carcinoma [see Warnings and Precautions (5.1)]<BR>                     <BR>                      Hypersensitivity Reactions [see Warnings and Precautions (5.2)]<BR>                     <BR>                      Dermatologic Reactions [see Warnings and Precautions (5.3)]<BR>                     <BR>                      QT Prolongation [see Warnings and Precautions (5.4)]<BR>                     <BR>                      Liver Laboratory Abnormalities [see Warnings and Precautions (5.5)]<BR>                     <BR>                      Photosensitivity [see Warnings and Precautions (5.6)]<BR>                     <BR>                      Ophthalmologic Reactions [see Warnings and Precautions (5.7)]<BR>                     <BR>                     New Primary Malignant Melanoma [see Warnings and Precautions (5.8)]<BR>                     <BR>                  <BR>               <BR>               <BR>               <BR>                  <BR>                     <BR>                        Most common adverse reactions (≥ 30%) are arthralgia, rash, alopecia, fatigue, photosensitivity reaction, nausea, pruritus and skin papilloma. (6.1)<BR>                        <BR><BR>                        <BR>                           To report SUSPECTED ADVERSE REACTIONS, contact Genentech at 1-888-835-2555 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.<BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     6.1	Clinical Trials Experience<BR>                     <BR>                        Because clinical studies are conducted under widely varying conditions, adverse reaction rates observed in the clinical studies of a drug cannot be directly compared to rates in the clinical studies of another drug and may not predict the rates observed in a broader patient population in clinical practice.<BR>                        The adverse drug reactions (ADRs) described in this section were identified from Trial 1 and Trial 2 [see Clinical Studies (14)]. In Trial 1, treatment naive patients with unresectable or metastatic melanoma (n=675) were allocated to ZELBORAF 960 mg orally twice daily or to dacarbazine 1000 mg/m2 intravenously every 3 weeks. In Trial 2, (n=132) patients with metastatic melanoma and failure of at least one prior systemic therapy received treatment with ZELBORAF 960 mg orally twice daily.  Adverse reactions reported in at least 10% of patients treated with ZELBORAF are presented in Table 2. The most common adverse reactions of any grade (≥ 30% in either study) reported in ZELBORAF-treated patients were arthralgia, rash, alopecia, fatigue, photosensitivity reaction, nausea, pruritus and skin papilloma. The most common (≥ 5%) Grade 3 adverse reactions were cuSCC and rash. The incidence of Grade 4 adverse reactions was ≤ 4% in both studies.<BR>                        The incidence of adverse events resulting in permanent discontinuation of study medication in Trial 1 was 7% for the ZELBORAF arm and 4% for the dacarbazine arm. In Trial 2, the incidence of adverse events resulting in permanent discontinuation of study medication was 3% in ZELBORAF-treated patients. The median duration of study treatment was 4.2 months for ZELBORAF and 0.8 months for dacarbazine in Trial 1, and 5.7 months for ZELBORAF in Trial 2.<BR>                        <BR><BR><table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" width="100%" ID="table2"><BR>                           <caption>Table 2     Adverse Reactions Reported in &#8805; 10% of Patients Treated with ZELBORAF<footnote>Adverse drug reactions, reported using MedDRA and graded using NCI-CTC-AE v 4.0 (NCI common toxicity criteria) for assessment of toxicity.</footnote><BR>                           </caption><BR>                           <col width="25%" align="left" valign="top"/><BR>                           <col width="8%" align="center" valign="top"/><BR>                           <col width="8%" align="center" valign="top"/><BR>                           <col width="8%" align="center" valign="top"/><BR>                           <col width="8%" align="center" valign="top"/><BR>                           <col width="8%" align="center" valign="top"/><BR>                           <col width="8%" align="center" valign="top"/><BR>                           <col width="9%" align="center" valign="top"/><BR>                           <col width="9%" align="center" valign="top"/><BR>                           <col width="9%" align="center" valign="top"/><BR>                           <thead><BR>                              <tr><BR>                                 <th styleCode="Lrule Rrule"/><BR>                                 <th styleCode="Rrule Botrule" colspan="6">Trial  1: Treatment Naive Patients</th><BR>                                 <th styleCode="Rrule Botrule" colspan="3">Trial 2: Patients with Failure of at Least One Prior Systemic Therapy</th><BR>                              </tr><BR>                              <tr><BR>                                 <th styleCode="Lrule Rrule"/><BR>                                 <th styleCode="Rrule Botrule" colspan="3">ZELBORAF<br/>n= 336</th><BR>                                 <th styleCode="Rrule Botrule" colspan="3">Dacarbazine<br/>n= 287</th><BR>                                 <th styleCode="Rrule Botrule" colspan="3">ZELBORAF<br/>n= 132</th><BR>                              </tr><BR>                              <tr><BR>                                 <th styleCode="Lrule Rrule" align="center">ADRs </th><BR>                                 <th>All Grades (%)</th><BR>                                 <th>Grade 3 (%)</th><BR>                                 <th styleCode="Rrule Toprule">Grade 4 (%)</th><BR>                                 <th>All Grades (%)</th><BR>                                 <th>Grade 3 (%)</th><BR>                                 <th styleCode="Rrule">Grade 4 (%)</th><BR>                                 <th>All Grades (%)</th><BR>                                 <th>Grade 3 (%)</th><BR>                                 <th styleCode="Rrule">Grade 4 (%)</th><BR>                              </tr><BR>                           </thead><BR>                           <tbody><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule"><BR>                                    <content styleCode="bold">Skin and subcutaneous tissue disorders</content><BR>                                 </td><BR>                                 <td/><BR>                                 <td/><BR>                                 <td styleCode="Rrule"/><BR>                                 <td/><BR>                                 <td/><BR>                                 <td styleCode="Rrule"/><BR>                                 <td/><BR>                                 <td/><BR>                                 <td styleCode="Rrule"/><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule">Rash</td><BR>                                 <td>37</td><BR>                                 <td>8</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>2</td><BR>                                 <td>-</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>52</td><BR>                                 <td>7</td><BR>                                 <td styleCode="Rrule">-</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule">Photosensitivity reaction</td><BR>                                 <td>33</td><BR>                                 <td>3</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>4</td><BR>                                 <td>-</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>49</td><BR>                                 <td>3</td><BR>                                 <td styleCode="Rrule">-</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule">Alopecia</td><BR>                                 <td>45</td><BR>                                 <td>&lt;1</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>2</td><BR>                                 <td>-</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>36</td><BR>                                 <td>-</td><BR>                                 <td styleCode="Rrule">-</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule">Pruritus</td><BR>                                 <td>23</td><BR>                                 <td>1</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>1</td><BR>                                 <td>-</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>30</td><BR>                                 <td>2</td><BR>                                 <td styleCode="Rrule">-</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule">Hyperkeratosis</td><BR>                                 <td>24</td><BR>                                 <td>1</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>&lt;1</td><BR>                                 <td>-</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>28</td><BR>                                 <td>-</td><BR>                                 <td styleCode="Rrule">-</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule">Rash maculo-papular</td><BR>                                 <td>9</td><BR>                                 <td>2</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>&lt;1</td><BR>                                 <td>-</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>21</td><BR>                                 <td>6</td><BR>                                 <td styleCode="Rrule">-</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule">Actinic keratosis</td><BR>                                 <td>8</td><BR>                                 <td>-</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>3</td><BR>                                 <td>-</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>17</td><BR>                                 <td>-</td><BR>                                 <td styleCode="Rrule">-</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule">Dry skin</td><BR>                                 <td>19</td><BR>                                 <td>-</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>1</td><BR>                                 <td>-</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>16</td><BR>                                 <td>-</td><BR>                                 <td styleCode="Rrule">-</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule">Rash papular</td><BR>                                 <td>5</td><BR>                                 <td>&lt;1</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>-</td><BR>                                 <td>-</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>13</td><BR>                                 <td>-</td><BR>                                 <td styleCode="Rrule">-</td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule Rrule">Erythema</td><BR>                                 <td>14</td><BR>                                 <td>-</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>2</td><BR>                                 <td>-</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>8</td><BR>                                 <td>-</td><BR>                                 <td styleCode="Rrule">-</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule"><BR>                                    <content styleCode="bold">Musculoskeletal and connective tissue disorders</content><BR>                                 </td><BR>                                 <td/><BR>                                 <td/><BR>                                 <td styleCode="Rrule"/><BR>                                 <td/><BR>                                 <td/><BR>                                 <td styleCode="Rrule"/><BR>                                 <td/><BR>                                 <td/><BR>                                 <td styleCode="Rrule"/><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule">Arthralgia</td><BR>                                 <td>53</td><BR>                                 <td>4</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>3</td><BR>                                 <td>&lt;1</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>67</td><BR>                                 <td>8</td><BR>                                 <td styleCode="Rrule">-</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule">Myalgia</td><BR>                                 <td>13</td><BR>                                 <td>&lt;1</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>1</td><BR>                                 <td>-</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>24</td><BR>                                 <td>&lt;1</td><BR>                                 <td styleCode="Rrule">-</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule">Pain in extremity</td><BR>                                 <td>18</td><BR>                                 <td>&lt;1</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>6</td><BR>                                 <td>2</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>9</td><BR>                                 <td>-</td><BR>                                 <td styleCode="Rrule">-</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule">Musculoskeletal pain</td><BR>                                 <td>8</td><BR>                                 <td>-</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>4</td><BR>                                 <td>&lt;1</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>11</td><BR>                                 <td>-</td><BR>                                 <td styleCode="Rrule">-</td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule Rrule">Back pain</td><BR>                                 <td>8</td><BR>                                 <td>&lt;1</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>5</td><BR>                                 <td>&lt;1</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>11</td><BR>                                 <td>&lt;1</td><BR>                                 <td styleCode="Rrule">-</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule"><BR>                                    <content styleCode="bold">General disorders and administration site conditions</content><BR>                                 </td><BR>                                 <td/><BR>                                 <td/><BR>                                 <td styleCode="Rrule"/><BR>                                 <td/><BR>                                 <td/><BR>                                 <td styleCode="Rrule"/><BR>                                 <td/><BR>                                 <td/><BR>                                 <td styleCode="Rrule"/><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule">Fatigue</td><BR>                                 <td>38</td><BR>                                 <td>2</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>33</td><BR>                                 <td>2</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>54</td><BR>                                 <td>4</td><BR>                                 <td styleCode="Rrule">-</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule">Edema peripheral</td><BR>                                 <td>17</td><BR>                                 <td>&lt;1</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>5</td><BR>                                 <td>-</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>23</td><BR>                                 <td>-</td><BR>                                 <td styleCode="Rrule">-</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule">Pyrexia</td><BR>                                 <td>19</td><BR>                                 <td>&lt;1</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>9</td><BR>                                 <td>&lt;1</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>17</td><BR>                                 <td>2</td><BR>                                 <td styleCode="Rrule">-</td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule Rrule">Asthenia</td><BR>                                 <td>11</td><BR>                                 <td>&lt;1</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>9</td><BR>                                 <td>&lt;1</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>2</td><BR>                                 <td>-</td><BR>                                 <td styleCode="Rrule">-</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule"><BR>                                    <content styleCode="bold">Gastrointestinal disorders</content><BR>                                 </td><BR>                                 <td/><BR>                                 <td/><BR>                                 <td styleCode="Rrule"/><BR>                                 <td/><BR>                                 <td/><BR>                                 <td styleCode="Rrule"/><BR>                                 <td/><BR>                                 <td/><BR>                                 <td styleCode="Rrule"/><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule">Nausea</td><BR>                                 <td>35</td><BR>                                 <td>2</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>43</td><BR>                                 <td>2</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>37</td><BR>                                 <td>2</td><BR>                                 <td styleCode="Rrule">-</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule">Diarrhea</td><BR>                                 <td>28</td><BR>                                 <td>&lt;1</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>13</td><BR>                                 <td>&lt;1</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>29</td><BR>                                 <td>&lt;1</td><BR>                                 <td styleCode="Rrule">-</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule">Vomiting</td><BR>                                 <td>18</td><BR>                                 <td>1</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>26</td><BR>                                 <td>1</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>26</td><BR>                                 <td>2</td><BR>                                 <td styleCode="Rrule">-</td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule Rrule">Constipation</td><BR>                                 <td>12</td><BR>                                 <td>&lt;1</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>24</td><BR>                                 <td>-</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>16</td><BR>                                 <td>-</td><BR>                                 <td styleCode="Rrule">-</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule"><BR>                                    <content styleCode="bold">Nervous system disorders</content><BR>                                 </td><BR>                                 <td/><BR>                                 <td/><BR>                                 <td styleCode="Rrule"/><BR>                                 <td/><BR>                                 <td/><BR>                                 <td styleCode="Rrule"/><BR>                                 <td/><BR>                                 <td/><BR>                                 <td styleCode="Rrule"/><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule">Headache</td><BR>                                 <td>23</td><BR>                                 <td>&lt;1</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>10</td><BR>                                 <td>-</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>27</td><BR>                                 <td>-</td><BR>                                 <td styleCode="Rrule">-</td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule Rrule">Dysgeusia</td><BR>                                 <td>14</td><BR>                                 <td>-</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>3</td><BR>                                 <td>-</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>11</td><BR>                                 <td>-</td><BR>                                 <td styleCode="Rrule">-</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule"><BR>                                    <content styleCode="bold">Neoplasms benign, malignant and unspecified (includes cysts and polyps)</content><BR>                                 </td><BR>                                 <td/><BR>                                 <td/><BR>                                 <td styleCode="Rrule"/><BR>                                 <td/><BR>                                 <td/><BR>                                 <td styleCode="Rrule"/><BR>                                 <td/><BR>                                 <td/><BR>                                 <td styleCode="Rrule"/><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule">Skin papilloma</td><BR>                                 <td>21</td><BR>                                 <td>&lt;1</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>-</td><BR>                                 <td>-</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>30</td><BR>                                 <td>-</td><BR>                                 <td styleCode="Rrule">-</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule">Cutaneous SCC<footnote>Includes both squamous cell carcinoma of the skin and keratoacanthoma.</footnote><BR>                                    <footnote>All cases of cutaneous squamous cell carcinoma were to be reported as Grade 3 per instructions to study investigators and no dose modification or interruption was required. </footnote><BR>                                 </td><BR>                                 <td>24</td><BR>                                 <td>22</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>&lt;1</td><BR>                                 <td>&lt;1</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>24</td><BR>                                 <td>24</td><BR>                                 <td styleCode="Rrule">-</td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule Rrule">Seborrheic keratosis</td><BR>                                 <td>10</td><BR>                                 <td>&lt;1</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>1</td><BR>                                 <td>-</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>14</td><BR>                                 <td>-</td><BR>                                 <td styleCode="Rrule">-</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule"><BR>                                    <content styleCode="bold">Investigations</content><BR>                                 </td><BR>                                 <td/><BR>                                 <td/><BR>                                 <td styleCode="Rrule"/><BR>                                 <td/><BR>                                 <td/><BR>                                 <td styleCode="Rrule"/><BR>                                 <td/><BR>                                 <td/><BR>                                 <td styleCode="Rrule"/><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule Rrule">Gamma-glutamyltransferase increased</td><BR>                                 <td>5</td><BR>                                 <td>3</td><BR>                                 <td styleCode="Rrule">&lt;1</td><BR>                                 <td>1</td><BR>                                 <td>-</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>15</td><BR>                                 <td>6</td><BR>                                 <td styleCode="Rrule">4</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule"><BR>                                    <content styleCode="bold">Metabolism and nutrition disorders</content><BR>                                 </td><BR>                                 <td/><BR>                                 <td/><BR>                                 <td styleCode="Rrule"/><BR>                                 <td/><BR>                                 <td/><BR>                                 <td styleCode="Rrule"/><BR>                                 <td/><BR>                                 <td/><BR>                                 <td styleCode="Rrule"/><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule Rrule">Decreased appetite</td><BR>                                 <td>18</td><BR>                                 <td>-</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>8</td><BR>                                 <td>&lt;1</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>21</td><BR>                                 <td>-</td><BR>                                 <td styleCode="Rrule">-</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule"><BR>                                    <content styleCode="bold">Respiratory, thoracic and mediastinal disorders</content><BR>                                 </td><BR>                                 <td/><BR>                                 <td/><BR>                                 <td styleCode="Rrule"/><BR>                                 <td/><BR>                                 <td/><BR>                                 <td styleCode="Rrule"/><BR>                                 <td/><BR>                                 <td/><BR>                                 <td styleCode="Rrule"/><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule Rrule">Cough</td><BR>                                 <td>8</td><BR>                                 <td>-</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>7</td><BR>                                 <td>-</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>12</td><BR>                                 <td>-</td><BR>                                 <td styleCode="Rrule">-</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule"><BR>                                    <content styleCode="bold">Injury, poisoning and procedural complications</content><BR>                                 </td><BR>                                 <td/><BR>                                 <td/><BR>                                 <td styleCode="Rrule"/><BR>                                 <td/><BR>                                 <td/><BR>                                 <td styleCode="Rrule"/><BR>                                 <td/><BR>                                 <td/><BR>                                 <td styleCode="Rrule"/><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule">Sunburn</td><BR>                                 <td>10</td><BR>                                 <td>-</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>-</td><BR>                                 <td>-</td><BR>                                 <td styleCode="Rrule">-</td><BR>                                 <td>14</td><BR>                                 <td>-</td><BR>                                 <td styleCode="Rrule">-</td><BR>                              </tr><BR>                           </tbody><BR>                        </table><BR>                        <BR><BR><BR>Clinically relevant adverse events reported in < 10% of patients treated with ZELBORAF in the Phase 2 and Phase 3 studies include:<BR>                        <BR>                           Skin and subcutaneous tissue disorders: palmar-plantar erythrodysaesthesia syndrome, keratosis pilaris, erythema nodosum, Stevens-Johnson syndrome<BR>                        <BR>                           Musculoskeletal and connective tissue disorders: arthritis<BR>                        <BR>                           Nervous system disorders: dizziness, neuropathy peripheral, VIIth nerve paralysis<BR>                        <BR>                           Neoplasms benign, malignant and unspecified (includes cysts and polyps): basal cell carcinoma<BR>                        <BR>                           Infections and infestations: folliculitis<BR>                        <BR>                           Investigations: weight decreased<BR>                        <BR>                           Eye disorders:  retinal vein occlusion, uveitis<BR>                        <BR>                           Vascular disorders: vasculitis<BR>                        <BR>                           Cardiac disorders: atrial fibrillation<BR>                        <BR>                           Table 3 shows the incidence of worsening liver laboratory abnormalities in Trial 1 summarized as the proportion of patients who experienced a shift from baseline to Grade 3 or 4.<BR>                        <BR><BR><table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" width="75%" ID="table3"><BR>                           <caption>Table 3     Change From Baseline to Grade 3/4 Liver Laboratory Abnormalities<footnote>For ALT, alkaline phosphatase and bilirubin, there were no patients with a change to grade 4 in either treatment arm.</footnote><BR>                           </caption><BR>                           <col width="34%" align="left" valign="top"/><BR>                           <col width="33%" align="center" valign="top"/><BR>                           <col width="33%" align="center" valign="top"/><BR>                           <thead><BR>                              <tr><BR>                                 <th styleCode="Lrule Rrule"/><BR>                                 <th styleCode="Rrule Botrule" colspan="2">Change From Baseline to Grade 3/4</th><BR>                              </tr><BR>                              <tr><BR>                                 <th styleCode="Lrule Rrule">Parameter</th><BR>                                 <th styleCode="Rrule">ZELBORAF (%)</th><BR>                                 <th styleCode="Rrule">Dacarbazine (%)</th><BR>                              </tr><BR>                           </thead><BR>                           <tbody><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule Rrule">GGT</td><BR>                                 <td styleCode="Rrule">11.5</td><BR>                                 <td styleCode="Rrule">8.6</td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule Rrule">AST</td><BR>                                 <td styleCode="Rrule">0.9</td><BR>                                 <td styleCode="Rrule">0.4</td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule Rrule">ALT</td><BR>                                 <td styleCode="Rrule">2.8</td><BR>                                 <td styleCode="Rrule">1.9</td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule Rrule">Alkaline phosphatase</td><BR>                                 <td styleCode="Rrule">2.9</td><BR>                                 <td styleCode="Rrule">0.4</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule">Bilirubin</td><BR>                                 <td styleCode="Rrule">1.9</td><BR>                                 <td styleCode="Rrule">-</td><BR>                              </tr><BR>                           </tbody><BR>                        </table><BR>                     <BR><BR><BR><BR>                     <BR>                  <BR>               <BR>            <BR>         </P></DIV></HTML>